rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1995-7-27
|
pubmed:abstractText |
R(+)-FIDA2, (R)-(+)-2,3-dimethoxy-5-iodo-N-[(1-(4'-fluorobenzyl)-2-pyrrolid iny l)- methyl]benzamide, is a new dopamine D2-like receptor imaging agent that can be labeled with either 123I or 18F for SPECT or PET imaging. The purpose of this study was to characterize its in vitro and in vivo binding properties.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1282-8
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7790957-Animals,
pubmed-meshheading:7790957-Autoradiography,
pubmed-meshheading:7790957-Benzamides,
pubmed-meshheading:7790957-Brain,
pubmed-meshheading:7790957-Dopamine Agonists,
pubmed-meshheading:7790957-Macaca fascicularis,
pubmed-meshheading:7790957-Male,
pubmed-meshheading:7790957-Pyrrolidines,
pubmed-meshheading:7790957-Rats,
pubmed-meshheading:7790957-Rats, Sprague-Dawley,
pubmed-meshheading:7790957-Receptors, Dopamine D2,
pubmed-meshheading:7790957-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1995
|
pubmed:articleTitle |
In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
|
pubmed:affiliation |
Department of Pharmacology, University of Pennsylvania, Philadelphia 19104, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|